FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.14
−1.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -3.03x
- Price / sales
- 6.69x
- Price / cash flow
- -2.88x
Enterprise value
- Enterprise value
- $121.4M
- EV / sales
- 3.30x
- EV / EBITDA
- -1.94x
- EV / EBIT
- -1.77x
- Market cap
- $245.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026